Skip to main content
. 2011 May 20;13(6):680–689. doi: 10.1093/neuonc/nor045

Table 2.

Treatment characteristics of pediatric patients with thalamic, pontine, and supratentorial high-grade gliomas

Characteristic No. (%) of patients
Thalamic high-grade glioma Pontine glioma Supratentorial high-grade glioma
Extent of surgical resection
 Gross total tumor resection 0 0 68 (38.4)
 Subtotal tumor resection 19 (19.2) 10 (4.2) 36 (20.3)
 Partial tumor resection 31 (31.3) 21 (9) 44 (24.9)
 Biopsy/no tumor surgery 49 (49.5) 203 (86.8) 29 (16.6)
Radiotherapy
 Yes 95 (96) 218 (93.2) 157 (88.7)
 No 4 (4) 16 (6.8) 20 (11.3)
Chemotherapy
 No 1 (1) 22 (9.4) 10 (5.6)
 HIT-GBM-A 1 (1) 14 (6) 11 (6.2)
 HIT-GBM-B 7 (7.1) 26 (11.1) 13 (7.3)
 HIT-GBM-C 26 (26.3) 54 (23.1) 37 (20.9)
 HIT-GBM-D 53 (53.5) 83 (35.5) 71 (40.1)
 Other chemotherapy 11 (11.1) 29 (12.4) 35 (19.9)